Professional
Added to YB: 2025-05-15
Pitch date: 2025-05-14
DNA [neutral]
Ginkgo Bioworks Holdings, Inc.
+4.53%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States.
Market Cap
$544.8M
Pitch Price
$7.73
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.13
P/E
-1.55
EV/Sales
3.84
Sector
Life Sciences Tools and Services
Category
growth
Pernas Research More Research Needed On: Ginkgo Bioworks Holdings, Inc.
DNA more research needed: Synthetic biology platform with AI/automation potential. Programs cells for pharma, agriculture & industrial uses. $200M revenue but -$200M annual losses. Strong $500M cash position. Waiting for progress on automation & AI capabilities to reach inflection point.
Read full article (1 min)